Quantcast
free-downloads CSEVideos


Haematopoetic stem cell and CVD

Discussion in 'Hematology' started by Valery1957, Feb 23, 2019.

  1. Valery1957

    Valery1957 Well-Known Member

    Joined:
    Jan 10, 2019
    Messages:
    143
    Likes Received:
    5
    Trophy Points:
    225
    Gender:
    Male
    Practicing medicine in:
    Belarus

    EDITOR'S CHOICE
    The haematopoietic stem cell niche: a new player in cardiovascular disease?
    https://doi.org/10.1093/cvr/cvy308
    Published:

    24 December 2018

    Article history

    Issue Section:
    Reviews
    1. Introduction
    The haematopoietic system is responsible for the production and maintenance of all blood cells within the body. This ranges from pluripotent haematopoietic stem and progenitor cells (HSPCs) through to mature fully differentiated leucocytes, erythrocytes, and platelets. The influence of the haematopoietic system on the progression of many diseases has been a topic of great interest throughout the last half century. In particular, the role that the mature immune cell compartment of the haematopoietic system plays in onset of disease, for example systemic inflammation and autoimmune disorders have received much attention. White blood cells, both of the innate and adaptive immune system, are implicated in both the exacerbation and resolution of inflammation. The dynamic nature of the white blood cell populations has generated significant interest into how inflammation can be regulated by modulation of immune cell function. In the setting of cardiovascular disease (CVD), it is now established that elevated numbers of circulating innate immune cells are strong predictors of atherosclerotic progression and cardiovascular events.View largeDownload slide
    Influence of the haematopoietic system on cardiovascular disease. The diagram represents a cycle of inflammation driven by immune cells. Within the BM, the site of primary haematopoiesis, the HSPCs begin to cycle and mobilize to the spleen. In the spleen, the HSPCs proliferate and differentiate into the downstream myeloid cells such as monocytes. The monocytes produced in the spleen are released into circulation, under the inflammatory conditions these splenic monocytes are particularly atherogenic. At the same time monocyte populations from the BM are released into the circulation. The circulating monocytes can then reach the site of arterial plaque formation, infiltrate the lesion, form macrophages, and propagate the inflammation. With an increase in atherogenesis and plaque instability the lesion may rupture, which is the major cause of myocardial infarction and stroke. Inflammatory signals from the infarcted heart and the plaque can return to the BM where they further exacerbate the haematopoietic dysfunction.
     

    Add Reply

Share This Page

<